Johnson & Johnson (NYSE:JNJ)

138.85
Delayed Data
As of May 24
 +0.01 / +0.01%
Today’s Change
118.62
Today|||52-Week Range
148.99
+7.59%
Year-to-Date
JNJ Regular Dividend: JNJ began trading ex-dividend on 05/24/19. A $0.95 dividend will be paid to shareholders of record as of 05/28/19.
Shares of Health Insurers Suffering at Prospect of Medicare for All
May 24 / GuruFocus NewsGURU - Paid Partner Content
This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock
May 20 / Zacks.comZAK - Paid Partner Content
Better Buy: Johnson & Johnson vs. GlaxoSmithKline
May 23 / MotleyFool.comFOO - Paid Partner Content
AbbVie's Brain Cancer Candidate Fails in Phase III Study
May 20 / Zacks.comZAK - Paid Partner Content
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
May 22 / Zacks.comZAK - Paid Partner Content
Johnson & Johnson to Participate in Bernstein's 35th Annual Strategic Decisions Confe...
May 17 / PR NewswirePRN - Paid Partner Content
The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM a...
May 21 / Zacks.comZAK - Paid Partner Content
Did Geron's Big Announcement Just Go Unnoticed?
May 16 / MotleyFool.comFOO - Paid Partner Content
Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs
May 20 / Zacks.comZAK - Paid Partner Content
Why Is Johnson & Johnson (JNJ) Down 1.2% Since Last Earnings Report?
May 16 / Zacks.comZAK - Paid Partner Content

Today’s Trading

Previous close138.84
Today’s open139.50
Day’s range138.56 - 139.50
Volume5,473,499
Average volume (3 months)6,539,067
Market cap$368.7B
Data as of 4:00pm ET, 05/24/2019

Growth & Valuation

Earnings growth (last year)+1,087.50%
Earnings growth (this year)+5.29%
Earnings growth (next 5 years)+5.73%
Revenue growth (last year)+6.61%
P/E ratio25.7
Price/Sales4.26
Price/Book6.19

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.03+0.07%
MRKMerck+0.15+0.19%
NVSNovartis+3.08+3.65%
ABTAbbott Laboratories+1.35+1.79%
Data as of 4:02pm ET, 05/24/2019

Financials

Next reporting dateJuly 16, 2019
EPS forecast (this quarter)$2.43
Annual revenue (last year)$81.5B
Annual profit (last year)$15.3B
Net profit margin18.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Executive Vice President
Joseph J. Wolk
Corporate headquarters
New Brunswick, New Jersey

Forecasts